BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
17:15
/
50%
€64.04
Target price
17.09.25
€80.92
Performance (%)
-0.91%
Price
22:26
€63.46
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc. is nearly unchanged. This prediction currently runs until 17.09.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | -0.91% |
iShares Core DAX® | 1.195% |
iShares Nasdaq 100 | 3.220% |
iShares Nikkei 225® | 1.858% |
iShares S&P 500 | 2.168% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Wells Fargo & Company from $115.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-18.67%
22:26
22:26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-17.58%
22:26
22:26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-20.99%
22:26
22:26